◼ Archived
Business
🔮 holds ✗
Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
Takeda secures FDA approval for Orzeyful, launching a new class of treatments targeting the underlying cause of narcolepsy type 1.